Access cutting-edge macular degeneration treatment through this clinical trial at a research site in St Petersburg. Study-provided care at no cost to qualified participants.
Access macular degeneration specialists in St Petersburg at no cost
This study follows strict safety protocols and ethical guidelines
All study-related macular degeneration treatment provided free
This is a phase 1/2 clinical study to evaluate the safety, preliminary efficacy, immunogenicity, and pharmacokinetic (PK) characteristics of SKG0106 in subjects with nAMD. Based on results from the phase 1 dose escalation study, the phase 2 expansion study will be conducted.
Sponsor: Skyline Therapeutics (US) Inc.
Check if you qualify for this macular degeneration clinical trial in St Petersburg, FL
If you're searching for macular degeneration treatment options in St Petersburg, FL, this clinical trial may be an excellent opportunity. Clinical trials provide access to cutting-edge treatments that aren't yet available to the general public, often at no cost to participants.
Our St Petersburg research site is actively enrolling participants for this clinical trial. You'll receive care from experienced macular degeneration specialists who are at the forefront of medical research. All study-related care, including examinations, treatments, and monitoring, is provided at no cost to qualified participants.